ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
2,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2,2,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2,4,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3,1,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
4,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
6,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6,3,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
6,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
7,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
7,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
8,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
9,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
10,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
11,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
12,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
12,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
13,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
13,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
13,3,Dyspnoea paroxysmal nocturnal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
13,4,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
13,5,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
14,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
15,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
16,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
17,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
17,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
17,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
18,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
19,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
19,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
19,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
20,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
21,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
23,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
24,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
24,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
24,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
25,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
25,2,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
25,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
26,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
26,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
26,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
27,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
27,2,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
27,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
28,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
29,1,Fistula of small intestine,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
30,1,Peritoneal fibrosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,Y
31,1,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
32,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
33,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
33,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
34,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
35,1,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
35,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
35,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
36,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
36,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
36,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
37,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
37,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
37,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
38,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
39,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
39,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
39,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
39,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
40,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
41,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
41,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
41,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
42,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
42,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,Y
43,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
44,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
45,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
45,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
46,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
46,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
46,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
47,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
47,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
48,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
49,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
49,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
49,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
50,1,Retinal degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
50,2,Retinal dystrophy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
51,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
52,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
53,1,Acquired hydrocele,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
53,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
54,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
54,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
55,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
55,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
55,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
55,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
56,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
56,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
56,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
57,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
57,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
57,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
57,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
57,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
58,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
58,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
58,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
58,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
58,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
59,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
60,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
61,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
62,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
63,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
63,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
64,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
64,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
65,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
66,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
67,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
67,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
68,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
69,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
70,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
71,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
72,1,Cardiogenic shock,Heart failures NEC,Heart failures,Card,Y
73,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
73,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
73,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
73,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
73,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
74,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
74,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
75,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
75,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
76,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
77,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
78,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,Y
79,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
80,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
81,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
81,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
81,3,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
81,4,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
81,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
82,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
83,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
83,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
84,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
84,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
84,4,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
85,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
86,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
86,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
86,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
86,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
87,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
88,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
89,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
90,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
91,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
92,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
92,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
93,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
94,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
94,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
95,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
95,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,3,Peripheral circulatory failure,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
95,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
96,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
97,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
97,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
97,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
98,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
98,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
98,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
99,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
100,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
101,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
101,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
102,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
103,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
103,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
104,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
105,1,Henoch-Schonlein purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
106,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
107,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
107,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
108,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
109,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
109,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
110,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
111,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
112,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
112,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
112,3,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
112,4,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
113,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
114,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
115,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
115,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
116,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
116,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
117,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
118,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
118,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
119,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
119,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
120,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
120,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
121,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
122,1,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
123,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
124,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
124,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
125,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
125,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
125,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
125,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
126,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
126,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
126,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
127,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
127,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
127,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
128,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
128,2,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
129,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
129,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
130,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
131,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
132,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
133,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
134,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
135,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
135,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
136,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
136,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
136,3,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
136,4,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
137,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
138,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
139,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
139,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
139,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
140,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
140,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
140,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
141,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
141,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
141,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
142,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
142,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
142,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
142,4,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
142,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
143,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
143,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
144,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
145,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
145,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
145,3,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
145,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
146,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
146,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
147,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
148,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
148,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
148,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
149,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
149,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
150,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
150,2,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
151,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
152,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
153,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
153,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
154,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
155,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
156,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
156,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
157,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
157,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
157,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
157,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
158,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
158,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
158,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
159,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
159,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
159,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
159,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
160,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
160,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
160,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
161,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
161,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
161,3,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
161,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
162,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
162,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
163,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
163,2,Palmar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
163,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
164,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
164,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
164,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
165,1,Myocardial fibrosis,Myocardial disorders NEC,Myocardial disorders,Card,N
166,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
167,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
167,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
168,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
168,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
168,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
169,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
169,2,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
169,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
169,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
170,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
170,2,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
171,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
171,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
171,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
172,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
173,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
174,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
174,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
175,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
176,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
176,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
177,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
178,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
179,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
180,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
180,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
181,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
181,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
182,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
183,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
183,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
183,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
183,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
183,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
184,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
184,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
184,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
184,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
185,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
186,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
187,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
187,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
187,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
188,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
189,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
189,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
189,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
189,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
189,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
190,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
191,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
192,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
192,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
192,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
193,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
193,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
194,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
195,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
196,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
196,2,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
197,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
198,1,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
199,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
200,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
201,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
202,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
202,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
202,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
203,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
204,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
204,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
204,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
204,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
204,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
204,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
205,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
205,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
205,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
205,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
206,1,Coronary artery insufficiency,Coronary artery disorders NEC,Coronary artery disorders,Card,N
207,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
208,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
209,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
210,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
211,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
211,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
212,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
213,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
213,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
213,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
214,1,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
214,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
214,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
214,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
215,1,Cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
216,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
216,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
217,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
217,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
217,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
218,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
218,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
218,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
219,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
219,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
219,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
219,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
220,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
220,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
221,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
221,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
221,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
221,4,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
221,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
221,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
221,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
221,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
221,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
222,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
222,2,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
222,3,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
222,4,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
223,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
224,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
224,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
225,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
225,2,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
226,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
227,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
227,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
228,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
229,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
230,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
231,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
232,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
233,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
234,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
235,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
235,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
235,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
235,4,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
235,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
236,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
236,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
237,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
237,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
237,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
237,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
238,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
239,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
239,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
239,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
240,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
241,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
242,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
243,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
243,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
243,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
243,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
244,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
244,2,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
244,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
244,4,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
244,5,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
244,6,Vaginal ulceration,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
245,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
245,2,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
246,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
246,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
246,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
246,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
246,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
247,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
248,1,Myocardial fibrosis,Myocardial disorders NEC,Myocardial disorders,Card,Y
249,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
249,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
250,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
250,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
250,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
251,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
252,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
253,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
254,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
255,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
256,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
256,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
256,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
256,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
256,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
256,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
257,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
257,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
257,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
257,4,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
257,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
257,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
257,7,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
257,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
258,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
258,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
258,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
258,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
259,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
260,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
261,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
261,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
261,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
261,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
262,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
262,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
262,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
262,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
263,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
264,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
265,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
265,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
265,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
265,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
265,5,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
266,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
267,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
267,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
268,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
269,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
270,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
271,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
272,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
273,1,Cardiac perforation,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
273,2,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
273,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
273,4,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
274,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
274,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
274,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
274,4,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
275,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
275,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
276,1,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
276,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
277,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
277,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
277,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
278,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
278,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
278,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
279,1,Sinoatrial block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
280,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
281,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
282,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
283,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
283,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
283,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
284,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
284,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
284,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
284,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
285,1,Meningitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
286,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
286,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
286,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
286,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
286,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
287,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
287,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
287,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
287,4,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
287,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
287,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
287,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
287,8,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
288,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
288,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
288,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
288,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
289,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
289,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
289,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
289,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
290,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
290,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
291,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
291,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
292,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
292,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
292,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
293,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
293,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
294,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
295,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
295,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
295,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
295,4,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
295,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
295,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
296,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
296,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
296,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
296,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
297,1,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
297,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
297,3,Phlebitis superficial,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
298,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
299,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
299,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
300,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
300,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
301,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
301,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
301,3,Blood albumin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
301,4,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
301,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
301,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
301,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
302,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
303,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
304,1,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
305,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
305,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
305,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
305,4,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
305,5,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
305,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
305,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
306,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
306,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
307,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
308,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
309,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
309,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
309,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
309,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
309,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
309,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
310,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
311,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
311,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
312,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
312,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
312,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
312,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
312,5,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
312,6,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
313,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
314,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
314,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
315,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
315,2,Meningitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,Y
315,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
315,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
316,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
317,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
318,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
319,1,Intussusception,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
320,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
321,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
321,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
321,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
322,1,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
322,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
322,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
323,1,Herpes zoster disseminated,Herpes viral infections,Viral infectious disorders,Infec,N
324,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
325,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
326,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
326,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
327,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
328,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
328,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
329,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
329,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
329,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
329,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
329,5,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
329,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
329,7,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
330,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
330,2,Lower respiratory tract inflammation,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
330,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
331,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
332,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
333,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
334,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
335,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
336,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
337,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
337,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
338,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
338,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
339,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
340,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
341,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
342,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
342,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
342,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
342,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
343,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
343,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
343,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
343,4,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
343,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
344,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
344,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
344,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
345,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
346,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
347,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
347,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
347,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
347,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
348,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
348,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
349,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
349,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
350,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
351,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
351,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
351,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
351,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
352,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
352,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
353,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
353,2,Headache,Headaches NEC,Headaches,Nerv,N
354,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
354,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
354,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
355,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
355,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
355,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
355,4,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
356,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
357,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
357,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
358,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
358,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
359,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
360,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
360,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
360,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
360,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
360,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
361,1,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
362,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
362,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
362,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
362,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
362,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
362,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
362,7,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
362,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
363,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
363,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
364,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
364,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
364,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
365,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
365,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
366,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
366,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
366,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
366,4,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
367,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
368,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
368,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
368,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
369,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
369,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
370,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
371,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
371,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
372,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
373,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
373,2,Headache,Headaches NEC,Headaches,Nerv,N
373,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
374,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
374,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
374,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
374,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
374,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
374,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
375,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
375,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
375,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
375,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
376,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
377,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
378,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
378,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
378,3,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
378,4,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
378,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
379,1,Acute myelomonocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
380,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
380,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
380,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
380,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
381,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
382,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
383,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
383,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
384,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
384,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
385,1,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,N
385,2,Congenital herpes simplex infection,Viral infections congenital,Infections and infestations congenital,Cong,N
385,3,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
385,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
386,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
386,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
386,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
386,4,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,Y
386,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
386,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
386,7,Traumatic lung injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
387,1,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,Y
388,1,Toxic cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
389,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
389,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
389,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
390,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
391,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
392,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
392,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
392,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
392,4,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
392,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
393,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
394,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
394,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
395,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
396,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
396,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
396,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
396,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
397,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
397,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
397,3,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
397,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
398,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
398,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
399,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
399,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
399,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
400,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
400,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
400,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
400,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
401,1,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
402,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
402,2,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
402,3,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
403,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
403,2,Nephroblastoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
404,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
404,2,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
405,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
405,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
406,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
407,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
407,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
407,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
407,4,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
407,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
408,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
408,2,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
408,3,Device related bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
408,4,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
408,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
408,6,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
408,7,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
408,8,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
408,9,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
408,10,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
408,11,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
408,12,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
408,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
408,14,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
408,15,Tic,Tic disorders,Changes in physical activity,Psych,N
409,1,Bladder fibrosis,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
409,2,Catheterisation venous,Venous therapeutic procedures,Vascular therapeutic procedures,Surg,N
409,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
409,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
409,5,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
409,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
409,7,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
410,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
411,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
412,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
413,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
414,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
415,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
415,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
415,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
415,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
415,5,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
415,6,Enterovirus infection,Enteroviral infections NEC,Viral infectious disorders,Infec,N
415,7,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
415,8,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
415,9,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
415,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
415,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
416,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
416,2,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
416,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
417,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
417,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
417,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
417,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
417,5,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
417,6,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
417,7,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
417,8,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
417,9,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
417,10,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
417,11,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
417,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
418,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
419,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
420,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
421,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
422,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
423,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
423,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
423,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
423,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
424,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
424,2,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
425,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
426,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
427,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
427,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
427,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
427,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
428,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
429,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
429,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
430,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
430,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
430,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
431,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
431,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
431,3,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
432,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
432,2,Bladder spasm,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
432,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
432,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
432,5,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
433,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
433,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
434,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
435,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
436,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
436,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
437,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
437,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
437,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
438,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,Y
438,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
439,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
439,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
439,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
439,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
439,5,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
439,6,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
439,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
439,8,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
439,9,Eschar,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
439,10,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
439,11,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
439,12,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
439,13,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
439,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
439,15,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
439,16,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
440,1,Atypical pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
440,2,Encephalitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,Y
440,3,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
440,4,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
440,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
440,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
441,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
441,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
442,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
442,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
443,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
443,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
444,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,Y
445,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
446,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
447,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
448,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
448,2,Headache,Headaches NEC,Headaches,Nerv,N
448,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
448,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
448,5,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
448,6,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
448,7,Vascular pain,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
449,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
449,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
449,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
449,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
449,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
450,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
451,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
451,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
451,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
452,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
453,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
454,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
455,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
455,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
455,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
455,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
455,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
456,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
456,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
456,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
456,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
456,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
457,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
457,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
457,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
457,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
458,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
459,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
460,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
460,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
460,3,Osteomyelitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
460,4,Thoracic vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
461,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
461,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
462,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
462,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
463,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
464,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
464,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
464,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
464,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
465,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
466,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
467,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
467,2,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
467,3,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
467,4,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
467,5,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
467,6,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
467,7,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
467,8,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
467,9,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
467,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
467,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
467,12,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
467,13,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
467,14,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
468,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
469,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
470,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
471,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
472,1,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
472,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
472,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
473,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
474,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
475,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
475,2,Haemangioma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
476,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
477,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
477,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
478,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
479,1,Burkitt's lymphoma recurrent,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
480,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
480,2,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
480,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
481,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
482,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
482,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
483,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
483,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
483,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
483,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
484,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
484,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
485,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
485,2,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
486,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
487,1,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
488,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
488,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
489,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
489,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
489,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
490,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
490,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
490,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
490,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
490,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
491,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
492,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
492,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
493,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
493,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
493,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
493,4,Gaze palsy,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
493,5,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
494,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
494,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
494,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
494,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
494,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
495,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
496,1,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
496,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
497,1,Hypopharyngeal cancer,Hypopharyngeal neoplasms malignant and unspecified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
498,1,Hypopharyngeal cancer,Hypopharyngeal neoplasms malignant and unspecified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
499,1,Oropharyngeal cancer,"Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified",Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
500,1,Hypopharyngeal cancer,Hypopharyngeal neoplasms malignant and unspecified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
501,1,Oropharyngeal cancer,"Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified",Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
502,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
502,2,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
503,1,Oropharyngeal cancer,"Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified",Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
504,1,Laryngeal cancer,Laryngeal neoplasms malignant,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
505,1,Hypopharyngeal cancer,Hypopharyngeal neoplasms malignant and unspecified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
506,1,Laryngeal cancer,Laryngeal neoplasms malignant,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
507,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
507,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
508,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
509,1,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
510,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
511,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
511,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
511,3,Diffuse large B-cell lymphoma stage II,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
511,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
511,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
511,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
511,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
511,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
511,9,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
511,10,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
511,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
511,12,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
512,1,Gallbladder rupture,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
512,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
512,3,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
512,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
512,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
513,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
513,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
514,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
515,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
516,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
517,1,Congenital hand malformation,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
517,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
518,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
518,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
519,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
519,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
520,1,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
520,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
520,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
521,1,Androgenetic alopecia,Alopecias,Skin appendage conditions,Skin,N
522,1,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
522,2,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
523,1,Follicular thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
524,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
525,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
526,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
526,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
527,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
527,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
528,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
528,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
529,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
529,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
530,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
530,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
531,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
531,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
532,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
532,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
533,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
533,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
534,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
534,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
535,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
536,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
537,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
538,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
539,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
540,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
540,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
541,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
541,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
542,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
542,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
543,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
543,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
544,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
544,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
545,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
545,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
546,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
546,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
547,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
547,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
548,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
548,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
549,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
549,2,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
549,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
550,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
550,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
550,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
550,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
550,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
550,6,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
550,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
550,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
550,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
550,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
550,11,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
551,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
552,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
552,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
552,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
553,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
553,2,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
554,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
554,2,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
554,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
554,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
554,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
554,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
554,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
554,8,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
554,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
554,10,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
555,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
556,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
556,2,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
557,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
557,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
558,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
558,2,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
558,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
558,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
558,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
558,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
558,7,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
558,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
558,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
558,10,Toxic cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
558,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
559,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
559,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
560,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
560,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
561,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
561,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
562,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
562,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
563,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
564,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
564,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
564,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
564,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
564,5,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
564,6,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
564,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
564,8,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
564,9,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
565,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
565,2,Pulmonary cavitation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
565,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
565,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
566,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
567,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
568,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
568,2,Complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
568,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
568,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
568,5,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
568,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
568,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
568,8,Periorbital cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
568,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
568,10,Vascular access complication,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
568,11,Vena cava thrombosis,Vena caval embolism and thrombosis,Embolism and thrombosis,Vasc,N
569,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
569,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
570,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
571,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
571,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
572,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
572,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
573,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
573,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
573,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
573,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
573,5,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
573,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
573,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
573,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
574,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
574,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
574,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
575,1,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
575,2,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
575,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
576,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
576,2,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
576,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
577,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
577,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
577,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
578,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
578,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
579,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
579,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
579,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
580,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
580,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
581,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
581,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
581,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
581,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
581,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
581,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
582,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
582,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
583,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
583,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
583,3,Implant site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
583,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
584,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
584,2,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
584,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
584,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
585,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
585,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
585,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
585,4,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
585,5,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
585,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
586,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,Y
587,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
587,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
588,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
588,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
589,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
589,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
589,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
590,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
591,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
592,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
593,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
593,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
593,3,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
593,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
594,1,Osmotic demyelination syndrome,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
595,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
596,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
597,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
598,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
599,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
599,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
599,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
599,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
600,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
600,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
601,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
602,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
602,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
603,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
603,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
603,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
604,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
604,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
604,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
605,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
605,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
605,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
605,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
606,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
606,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
606,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
607,1,Osmotic demyelination syndrome,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
608,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
608,2,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
608,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
608,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
609,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
609,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
610,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
610,2,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
610,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
610,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
610,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
610,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
610,7,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
610,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
610,9,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
610,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
610,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
610,12,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
611,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
611,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
612,1,Candida test positive,Fungus identification and serology,Microbiology and serology investigations,Inv,N
612,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
612,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
612,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
612,5,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
612,6,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
612,7,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
612,8,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
612,9,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
613,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
613,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
613,3,Salivary gland cancer,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
614,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
614,2,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
614,3,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
615,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
615,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
615,3,Headache,Headaches NEC,Headaches,Nerv,N
615,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
615,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
615,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
616,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
616,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
617,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
617,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
618,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
618,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
619,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
619,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
620,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
620,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
621,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
621,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
621,3,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
621,4,Myelodysplastic syndrome with excess blasts,Myelodysplastic syndromes,Leukaemias,Neopl,N
621,5,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
621,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
622,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
622,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
623,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
623,2,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
623,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
623,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
623,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
623,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
624,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
624,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
624,3,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
625,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
625,2,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
626,1,Sarcoma of skin,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
627,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
628,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
629,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
629,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
630,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
630,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
631,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
631,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
632,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
633,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
633,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
633,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
633,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
633,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
633,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
633,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
633,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
633,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
634,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
634,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
634,3,Stenotrophomonas sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
635,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
635,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
635,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
636,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
637,1,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
638,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
639,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
639,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
639,3,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
640,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
640,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
640,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
640,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
640,5,Sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
640,6,Sarcoma metastatic,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
640,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
640,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
641,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
642,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
642,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
642,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
643,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
644,1,Testicular neoplasm,Reproductive neoplasms male unspecified malignancy,Reproductive neoplasms male malignant and unspecified,Neopl,N
645,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
646,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
647,1,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
648,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
649,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
649,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
649,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
649,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
649,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
649,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
649,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
650,1,Castleman's disease,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
650,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
651,1,Diffuse large B-cell lymphoma stage IV,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
652,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
652,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
652,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
652,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
652,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
652,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
653,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
653,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
654,1,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
654,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
655,1,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
655,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
656,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
656,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
656,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
656,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
656,5,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
656,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
657,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
657,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
657,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
657,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
657,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
657,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
658,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
659,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
659,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
659,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
660,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
660,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
660,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
660,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
660,5,Duodenal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
660,6,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
660,7,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
660,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
660,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
660,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
661,1,Chondrosarcoma metastatic,Cartilage sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
661,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
662,1,Encephalitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,N
663,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
663,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
664,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
664,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
664,3,Migraine,Migraine headaches,Headaches,Nerv,N
664,4,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
665,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
665,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
665,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
665,4,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
666,1,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
666,2,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
667,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
667,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
667,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
667,4,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
667,5,Small cell lung cancer,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
668,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
668,2,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
668,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
668,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
668,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
668,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
669,1,Peripheral T-cell lymphoma unspecified,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
670,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
670,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
670,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
670,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
671,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
671,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
672,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
672,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
673,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
673,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
673,3,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,Y
673,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
673,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
673,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
674,1,Primitive neuroectodermal tumour,Nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
675,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
676,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
677,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
678,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
679,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
680,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
681,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
681,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
681,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
682,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
682,2,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
682,3,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
683,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
684,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
684,2,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
684,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
684,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
684,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
684,6,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
684,7,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
684,8,Hepatitis B DNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
684,9,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
684,10,Hepatitis B surface antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
684,11,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
684,12,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
684,13,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
684,14,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
684,15,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
685,1,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
685,2,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
686,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
686,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
686,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
686,4,Metastases to spine,Metastases to specified sites,Metastases,Neopl,N
686,5,Pelvic mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
687,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
688,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
688,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
689,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
690,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
690,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
690,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
690,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
691,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
691,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
692,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
693,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
694,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
694,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
694,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
694,4,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
695,1,Ewing's sarcoma recurrent,Bone sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
696,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
696,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
697,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
697,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
697,3,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
698,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
699,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
700,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
701,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
702,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
702,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
702,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
703,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
704,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
704,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
704,3,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
705,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
705,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
705,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
705,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
705,5,Subdural hygroma,Structural brain disorders NEC,Structural brain disorders,Nerv,N
705,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
706,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
707,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
707,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
708,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
709,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
709,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
709,3,Immobile,Disability issues,Lifestyle issues,SocCi,N
709,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
709,5,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
710,1,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
710,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
711,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
711,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
712,1,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
712,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
713,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
713,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
713,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
713,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
713,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
714,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
715,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
716,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
716,2,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
717,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
717,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
717,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
717,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
717,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
718,1,Cardiac function test abnormal,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
718,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
718,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
719,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
720,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
720,2,Headache,Headaches NEC,Headaches,Nerv,N
720,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
720,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
721,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
721,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
722,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
722,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
722,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
723,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
723,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
723,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
724,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
724,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
724,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
725,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
725,2,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
725,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
725,4,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
725,5,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
725,6,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
725,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
725,8,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
725,9,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
725,10,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
725,11,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
725,12,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
725,13,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
726,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
726,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
727,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
728,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
728,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
728,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
729,1,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
729,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
730,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
731,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
732,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
732,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
732,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
733,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
734,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
735,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
736,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
737,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
737,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
737,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
737,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
737,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
738,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
739,1,Laryngeal cancer,Laryngeal neoplasms malignant,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
739,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
740,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
740,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
741,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
741,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
741,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
741,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
741,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
742,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
742,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
742,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
743,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
743,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
743,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
743,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
744,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
744,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
745,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
746,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
746,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
747,1,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
748,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
749,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
749,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
749,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
749,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
749,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
749,6,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
749,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
750,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
750,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
751,1,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
752,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
752,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
752,3,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
752,4,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
752,5,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
753,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
753,2,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
753,3,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
753,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
753,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
753,6,Myocardial fibrosis,Myocardial disorders NEC,Myocardial disorders,Card,Y
754,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
755,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
756,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
756,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
757,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
757,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
757,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
758,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
759,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
759,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
759,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
759,4,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
759,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
759,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
759,7,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
759,8,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
759,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
759,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
759,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
759,12,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
760,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
761,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
761,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
761,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
761,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
761,5,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
762,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
762,2,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
762,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
762,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
762,5,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
762,6,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
762,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
762,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
763,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
763,2,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
764,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
764,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
764,3,Plantar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
764,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
765,1,"Follicle centre lymphoma, follicular grade I, II, III recurrent",Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
765,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
766,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
766,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
767,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
767,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
767,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
767,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
767,5,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
767,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
767,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
768,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
768,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
768,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
769,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
769,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
769,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
769,4,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
770,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
771,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
772,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
772,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
772,3,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
773,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
774,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
775,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
775,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
775,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
776,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
777,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
777,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
777,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
778,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
778,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
778,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
778,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
779,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
779,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
779,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
779,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
780,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
780,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
780,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
781,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
781,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
781,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
781,4,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
781,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
781,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
782,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
782,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
782,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
782,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
782,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
782,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
782,7,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
782,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
782,9,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
782,10,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
782,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
783,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
784,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
785,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
785,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
786,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
786,2,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
786,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
787,1,Dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
788,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
788,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
789,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
790,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
790,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
790,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
791,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
791,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
791,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
792,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
792,2,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
793,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
793,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
793,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
794,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
794,2,Herpes zoster oticus,Herpes viral infections,Viral infectious disorders,Infec,N
794,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
794,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
795,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
796,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
797,1,Ovarian failure,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
798,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
798,2,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
798,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
798,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
798,5,Complement factor C3 decreased,Immune response protein analyses NEC,Immunology and allergy investigations,Inv,N
798,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
798,7,Glomerulonephritis rapidly progressive,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
798,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
798,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
798,10,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
798,11,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
798,12,Red blood cells urine positive,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
799,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
799,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
799,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
799,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
799,5,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
800,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
801,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
802,1,Desmoid tumour,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
803,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
804,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
804,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
805,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
805,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
806,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
806,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
806,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
806,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
806,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
806,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
807,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
808,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
808,2,Mantle cell lymphoma recurrent,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
808,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
808,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
809,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
809,2,Cardiogenic shock,Heart failures NEC,Heart failures,Card,Y
809,3,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
810,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
810,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
811,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
811,2,Subdural hygroma,Structural brain disorders NEC,Structural brain disorders,Nerv,Y
811,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
812,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
812,2,Mantle cell lymphoma recurrent,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
812,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
812,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
812,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
813,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
813,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
813,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
813,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
814,1,Dermatitis infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
814,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
815,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
815,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
816,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
816,2,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
817,1,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
817,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
818,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
818,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
818,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
819,1,Dysaesthesia pharynx,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
819,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
819,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
819,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
820,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
820,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
820,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
820,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
820,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
821,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
822,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
822,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
823,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
823,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
824,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
825,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
826,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
827,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
828,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
828,2,Desmoplastic small round cell tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
828,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
828,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
828,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
828,6,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
828,7,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
828,8,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
828,9,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
828,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
828,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
828,12,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
829,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
829,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
829,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
829,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
830,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
830,2,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
831,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
832,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
833,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
834,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
835,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
836,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
836,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
837,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
837,2,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
838,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
838,2,Hodgkin's disease lymphocyte predominance type refractory,Hodgkin's disease lymphocyte predominance type,Lymphomas Hodgkin's disease,Neopl,N
839,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
839,2,Hodgkin's disease lymphocyte predominance type refractory,Hodgkin's disease lymphocyte predominance type,Lymphomas Hodgkin's disease,Neopl,N
840,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
840,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
840,3,Infective aneurysm,Vascular infections,Infections - pathogen unspecified,Infec,N
840,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
840,5,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
840,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
840,7,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
840,8,Vascular pseudoaneurysm,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
841,1,Hodgkin's disease refractory,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
841,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
842,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
842,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
842,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
842,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
842,5,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
842,6,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
842,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
843,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
843,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
843,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
844,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
844,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
845,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
846,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
847,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
847,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
847,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
848,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
848,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
849,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
849,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
849,3,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
849,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
850,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
850,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
851,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
852,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
852,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
852,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
853,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
854,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
854,2,Neuroblastoma,Nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
854,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
855,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
856,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
856,2,Rhabdoid tumour,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
857,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
858,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
858,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
858,3,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
858,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
858,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
858,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
859,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
860,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
860,2,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
860,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
861,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
862,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
862,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
862,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
863,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
863,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
863,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
863,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
864,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
865,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
865,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
866,1,Burkitt's lymphoma recurrent,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
866,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
867,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
867,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
868,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
869,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
869,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
869,3,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
869,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
869,5,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
870,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
871,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
871,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
871,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
871,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
872,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
872,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
872,3,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
872,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
872,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
873,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
873,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
874,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
874,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
875,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
876,1,Cutaneous T-cell lymphoma recurrent,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
877,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
877,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
877,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
878,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
878,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
879,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
879,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
879,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
880,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
880,2,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
880,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
880,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
880,5,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
880,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
881,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
881,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
881,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
881,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
882,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
882,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
882,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
883,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
883,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
883,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
884,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
885,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
886,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
886,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
886,3,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
887,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
887,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
888,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
888,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
888,3,Forced expiratory volume decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
888,4,Funnel chest acquired,Trunk deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
888,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
888,6,Pleural fibrosis,Pleural conditions NEC,Pleural disorders,Resp,N
888,7,Pleural thickening,Pleural conditions NEC,Pleural disorders,Resp,N
888,8,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
888,9,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
888,10,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
889,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
890,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
891,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
892,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
892,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
892,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
892,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
892,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
892,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
892,7,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
892,8,Natural killer-cell lymphoblastic lymphoma,Precursor T-lymphoblastic lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,N
892,9,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
892,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
893,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
894,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
895,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
896,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
896,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
897,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
897,2,Cholestatic liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
898,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
898,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
898,3,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
898,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
899,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
900,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
901,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
901,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
901,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
901,4,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
901,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
902,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
902,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
902,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
903,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
904,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
905,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
906,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
906,2,Headache,Headaches NEC,Headaches,Nerv,N
906,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
906,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
906,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
906,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
907,1,B-cell lymphoma stage IV,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
907,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
907,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
907,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
908,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
908,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
908,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
908,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
908,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
908,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
909,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
909,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
909,3,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
909,4,Heart failure with reduced ejection fraction,Left ventricular failures,Heart failures,Card,N
909,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
909,6,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
910,1,Gastroenteritis salmonella,Salmonella infections,Bacterial infectious disorders,Infec,N
910,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
911,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
912,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
913,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
914,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
914,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
914,3,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
914,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
915,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
916,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
917,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
917,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
917,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
917,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
917,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
917,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
917,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
918,1,Peripheral T-cell lymphoma unspecified,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
918,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
919,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
919,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
920,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
920,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
920,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
920,4,Pulmonary cavitation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
921,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
921,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
921,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
921,4,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
922,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
922,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
923,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
923,2,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
923,3,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
923,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
923,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
923,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
923,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
923,8,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
923,9,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
923,10,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
923,11,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
923,12,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
923,13,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
923,14,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
923,15,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
923,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
924,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
924,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
924,3,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
924,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
924,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
924,6,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
924,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
925,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
925,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
926,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
926,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
926,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
926,4,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
927,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
927,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
927,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
927,4,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
927,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
928,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
928,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
928,3,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
928,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
929,1,Acute biphenotypic leukaemia,Leukaemias acute NEC,Leukaemias,Neopl,N
929,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
929,3,Blast cells present,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
929,4,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
929,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
929,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
929,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
929,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
929,9,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
929,10,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
929,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
930,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
930,2,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
930,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
931,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
931,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
932,1,Calcification metastatic,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,Y
932,2,Chondrosarcoma metastatic,Cartilage sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
932,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
932,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
932,5,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
932,6,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
932,7,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
932,8,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
933,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
933,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
934,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
935,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
935,2,Pulmonary function test abnormal,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,Y
935,3,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
936,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
936,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
936,3,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
936,4,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
937,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
938,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
938,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
938,3,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
939,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
940,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
940,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
940,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
941,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
942,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
942,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
942,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
943,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
943,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
943,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
944,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
944,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
945,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
945,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
945,3,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
945,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
946,1,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
946,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
947,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
948,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
949,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
949,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
949,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
949,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
950,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
950,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
951,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
952,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
952,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
952,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
952,4,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
952,5,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
952,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
953,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
953,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
953,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
953,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
953,5,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
954,1,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
954,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
954,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
954,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
954,5,Stoma site reaction,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
955,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
956,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
957,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
958,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
958,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
958,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
959,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
960,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
960,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
960,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
961,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
962,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
962,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
963,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
963,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
964,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
964,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
964,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
965,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
965,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
965,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
966,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
966,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
966,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
966,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
967,1,Cytology abnormal,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
967,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
968,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
968,2,Pharyngeal erythema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
968,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
969,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
969,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
969,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
969,4,Headache,Headaches NEC,Headaches,Nerv,N
969,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
970,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
970,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
970,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
971,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
971,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
971,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
971,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
971,5,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
971,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
972,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
972,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
973,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
973,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
973,3,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
973,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
974,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
975,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
976,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
977,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
977,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
977,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
978,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
978,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
979,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
979,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
980,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
980,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
980,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
980,4,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
980,5,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
981,1,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
982,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
982,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
982,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
983,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
983,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
983,3,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
983,4,Hypofibrinogenaemia,Coagulation factor deficiencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
983,5,Low cardiac output syndrome,Heart failures NEC,Heart failures,Card,N
983,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
983,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
983,8,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
983,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
983,10,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
984,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
984,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
984,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
984,4,Waldenstrom's macroglobulinaemia,Waldenstrom's macroglobulinaemias,Lymphomas non-Hodgkin's B-cell,Neopl,Y
985,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
985,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
985,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
986,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
986,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
987,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
987,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
987,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
987,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
987,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
988,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
988,2,Ovarian cancer stage IV,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
989,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
989,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
989,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
989,4,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
989,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
989,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
989,7,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
989,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
990,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
991,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
991,2,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
992,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
993,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
994,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
995,1,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
995,2,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
996,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
996,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
996,3,Squamous cell carcinoma of head and neck,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
997,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
997,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
997,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
998,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
999,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1000,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1000,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1001,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1002,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1003,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1003,2,Paraneoplastic dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
1004,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1004,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1005,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1005,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1005,3,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1005,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1005,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1005,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1005,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1005,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1005,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1005,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1006,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1006,2,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1006,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1007,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1008,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1008,2,Bone infarction,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1008,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1008,4,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
1008,5,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1008,6,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1009,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1009,2,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1009,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1009,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
1010,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1011,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1011,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1011,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1011,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1012,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1013,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1013,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1013,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1014,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1014,2,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1014,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1015,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1015,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1015,3,Purpura fulminans,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1015,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1016,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1016,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1016,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1016,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1016,5,Purpura fulminans,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1016,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1017,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1017,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1017,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1017,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1017,5,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1018,1,Extramedullary haemopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
1018,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1019,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1020,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1020,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1020,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1021,1,Systolic dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1022,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1023,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1023,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1023,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1023,4,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1023,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1023,6,Rebound psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1023,7,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1023,8,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1023,9,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1024,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1025,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1026,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1027,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1027,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1027,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1027,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1027,5,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1028,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1028,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1029,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1030,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
1030,2,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
1030,3,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
1030,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1031,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
1031,2,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
1031,3,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
1031,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1032,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1033,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1034,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1034,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1034,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1035,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1036,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1036,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1036,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1036,4,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1036,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1036,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1036,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1036,8,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1036,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1036,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1037,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1037,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1038,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1038,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1038,3,Squamous cell carcinoma of head and neck,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1039,1,Eosinophilic fasciitis,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1040,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1040,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1040,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1041,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1042,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1042,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1043,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1043,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1044,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1044,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1045,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1046,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1046,2,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1046,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1047,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1047,2,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1047,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1048,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1049,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1050,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1050,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1050,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1051,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1051,2,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1051,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1052,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1052,2,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1052,3,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1052,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1052,5,Headache,Headaches NEC,Headaches,Nerv,N
1052,6,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1052,7,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1053,1,Bone deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1053,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1053,3,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1053,4,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1054,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
1054,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1054,3,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1054,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1054,5,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1054,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1054,7,Pancreatic mass,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
1054,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1054,9,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1055,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1055,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1056,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1057,1,Eosinophilic fasciitis,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1058,1,Bone deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1058,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1058,3,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1058,4,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1059,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1059,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1059,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1060,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1061,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1061,2,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
1061,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1061,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1061,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1061,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1061,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1061,8,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
1062,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
1063,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1063,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1063,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1064,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1064,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1064,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1064,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1065,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1065,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1065,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1066,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
1067,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
1068,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
1069,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1070,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1071,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1072,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
1073,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1074,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
1075,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1076,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1076,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1076,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1076,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1077,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1078,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1078,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1078,3,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
1079,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1079,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1080,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
1080,2,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
1080,3,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
1080,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1081,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1082,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1082,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1082,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1082,4,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1082,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1082,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1082,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1082,8,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1082,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1082,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1083,1,Ejection fraction abnormal,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1083,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1083,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1084,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1084,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1084,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1085,1,Bone deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1085,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1085,3,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1085,4,Optic nerve injury,Cranial nerve injuries,Injuries NEC,Inj&P,N
1085,5,Transverse sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1086,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1086,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1087,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1087,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1087,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1088,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1088,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1089,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1089,2,Headache,Headaches NEC,Headaches,Nerv,N
1089,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1089,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1089,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1090,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1090,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1090,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1090,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1090,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1091,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1092,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1093,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1094,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1095,1,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1096,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1096,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1097,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1097,2,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1098,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1098,2,Pathological fracture,Fractures NEC,Fractures,Musc,N
1098,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1098,4,Ureterolithiasis,Urinary tract lithiasis NEC,Urolithiases,Renal,N
1099,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1099,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1100,1,Bone deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1100,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1100,3,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1100,4,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1101,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1101,2,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1102,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1103,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1103,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1104,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1104,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1104,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1105,1,Candida sepsis,Candida infections,Fungal infectious disorders,Infec,N
1105,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1105,3,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
1106,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1106,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1107,1,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,N
1107,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1107,3,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1107,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1107,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1107,6,Pulmonary alveolar haemorrhage,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1107,7,Restrictive cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
1107,8,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1107,9,Systolic dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1107,10,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1108,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1109,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1110,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1111,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1112,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1113,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1114,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1115,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1116,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1117,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1118,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1119,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1120,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1121,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1122,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1123,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1124,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1125,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1126,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1127,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1128,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1129,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1130,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1131,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1132,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1133,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1134,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1135,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1136,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1137,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1138,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1139,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1140,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1141,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1142,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1143,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1144,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1145,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1146,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1147,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1148,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1149,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1150,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1151,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1152,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1153,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1154,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1155,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1156,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1157,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1158,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1159,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1160,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1161,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1162,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1163,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1164,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1165,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1166,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1167,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1168,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1169,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1170,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1171,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1172,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1173,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1174,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1175,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1176,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1177,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1178,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1179,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1180,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1181,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1182,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1183,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1184,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1185,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1186,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1187,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1188,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1189,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1190,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1191,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1192,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1193,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1194,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1195,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1196,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1197,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1198,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1199,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1200,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1201,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1202,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1203,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1204,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1205,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1206,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1207,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1208,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1209,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1210,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1211,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1212,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1213,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1214,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1215,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1216,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1217,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1218,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1219,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1220,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1221,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1222,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1223,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1224,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1225,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1226,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1227,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1228,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1229,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1230,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1231,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1232,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1233,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1234,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1235,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1236,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1237,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1238,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1239,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1240,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1241,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1242,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1243,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1244,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1245,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1246,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1246,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1246,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1246,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1246,5,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
1246,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1247,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1248,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1249,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1250,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1251,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1252,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1253,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1254,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1255,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1256,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1257,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1258,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1259,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1260,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1261,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1262,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1263,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1264,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1265,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1266,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1267,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1268,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1269,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1270,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1271,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1272,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1273,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1274,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1275,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1276,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1277,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1278,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1279,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1280,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1281,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1282,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1283,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1284,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1285,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1286,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1287,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1288,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1289,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1290,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1291,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1292,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1293,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1294,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1295,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1296,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1297,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1298,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1298,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1298,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1299,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1299,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1299,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1300,1,Extramedullary haemopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
1300,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1301,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1301,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1302,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1302,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1303,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1303,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1303,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1303,4,Placenta accreta,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
1303,5,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1304,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1304,2,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
1304,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1304,4,Positive airway pressure therapy,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
1304,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1305,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1305,2,Heart failure with reduced ejection fraction,Left ventricular failures,Heart failures,Card,N
1305,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1306,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1306,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1306,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1306,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1306,5,Transfusion-related circulatory overload,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
1306,6,Traumatic haematoma,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1307,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1307,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1308,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1308,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1308,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1309,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1310,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1310,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1310,3,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1310,4,Heart failure with reduced ejection fraction,Left ventricular failures,Heart failures,Card,N
1310,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1310,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1311,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1311,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1311,3,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1311,4,Heart failure with reduced ejection fraction,Left ventricular failures,Heart failures,Card,N
1312,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1313,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,Y
1314,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1314,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1314,3,Congestive hepatopathy,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1314,4,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1314,5,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1314,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1315,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1316,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1316,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1316,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1317,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1318,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1318,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1319,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1320,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1320,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1320,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1320,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1320,5,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1320,6,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
1320,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1320,8,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1320,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1320,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1320,11,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1320,12,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
1320,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1320,14,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1321,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1321,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1321,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1322,1,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1322,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1322,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1322,4,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1323,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1324,1,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1325,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1325,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1326,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1327,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1328,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1329,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1329,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1329,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1330,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1330,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1331,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1331,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1331,3,High-grade B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1331,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1331,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1331,6,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1331,7,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1331,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1332,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1333,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1334,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1335,1,Cardiac dysfunction,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1335,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1336,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1336,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1337,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
1338,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1338,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1339,1,Blood pressure diastolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1339,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1340,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1341,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1341,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1341,3,Intestinal stenosis,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1342,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
1343,1,Blood pressure diastolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1343,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1344,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1344,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1344,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1344,4,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
1344,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1344,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1345,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1345,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1345,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1345,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1345,5,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1345,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1345,7,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1346,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1347,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1348,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1349,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1350,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1351,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1351,2,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
1352,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1352,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1352,3,Headache,Headaches NEC,Headaches,Nerv,N
1352,4,Hemianopia homonymous,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
1352,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1352,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1352,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1353,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1354,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1354,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1355,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1355,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1355,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1355,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1355,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1355,6,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1355,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1355,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1356,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1356,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1356,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1357,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1358,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1359,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1359,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1360,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1360,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1361,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1362,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1362,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1362,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1362,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1363,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1363,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1364,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1364,2,Immunoblastic lymphoma,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
1365,1,Immunoblastic lymphoma,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1365,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1366,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1366,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1367,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1367,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1368,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1368,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1368,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1369,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1369,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1370,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1371,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1372,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1373,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1374,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1374,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1374,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1374,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1374,5,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1375,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1375,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1375,3,Papillary renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1376,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1376,2,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
1377,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1377,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1377,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1377,4,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1377,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1378,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1379,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1380,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1380,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1380,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1380,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1380,5,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1380,6,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1380,7,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1380,8,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1381,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1382,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1382,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1382,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1382,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1382,5,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1382,6,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1382,7,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1382,8,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1383,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1384,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1384,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1384,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1384,4,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1384,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1384,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1384,7,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1384,8,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1384,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1384,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1385,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1385,2,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1385,3,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1385,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1385,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1385,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1385,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1385,8,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1385,9,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1385,10,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1385,11,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1385,12,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1385,13,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1385,14,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1385,15,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1385,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1386,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1386,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1386,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1386,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1386,5,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1386,6,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1387,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1388,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1388,2,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1389,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1389,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1389,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1390,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1390,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1391,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1391,2,T-cell lymphoma refractory,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
1392,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1392,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1392,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1392,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1392,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1392,6,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1393,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1393,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1393,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1393,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1394,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1395,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1395,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1396,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1396,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1397,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1398,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1398,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1399,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1399,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1399,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1400,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1400,2,Laboratory test interference,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1401,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1401,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1401,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1402,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1402,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1402,3,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
1402,4,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1402,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1403,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1403,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1404,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1405,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1406,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1407,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1408,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1409,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1410,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1410,2,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1410,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1410,4,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
1410,5,Human herpesvirus 6 encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
1410,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1410,7,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
1411,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1412,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1412,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1413,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1414,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1414,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1414,3,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1415,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1416,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1416,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1416,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1417,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1417,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1417,3,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
1418,1,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1418,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1418,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1418,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1418,5,Stoma site reaction,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
1419,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1419,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1419,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1419,4,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
1419,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1420,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1420,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1420,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1420,4,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
1421,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1421,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1421,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
1422,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1423,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1424,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1424,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1424,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1425,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1426,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1426,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1427,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1427,2,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1428,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1428,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1428,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1428,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1428,5,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1429,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1430,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1431,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1432,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1432,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1433,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1433,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1433,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1434,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1434,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1435,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1436,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1436,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1436,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1437,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1437,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1437,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1437,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1438,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1438,2,Anal inflammation,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
1438,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1438,4,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1438,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1438,6,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1438,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1438,8,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1438,9,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
1438,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1438,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1438,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1438,13,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
1438,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1438,15,SARS-CoV-2 test negative,Virus identification and serology,Microbiology and serology investigations,Inv,N
1438,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1439,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1439,2,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
1440,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1441,1,Anaplastic large cell lymphoma T- and null-cell types,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
1442,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1443,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1443,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1444,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1444,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1445,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1445,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1446,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1446,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1447,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1448,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1449,1,Bone scan abnormal,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
1449,2,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1449,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1449,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1449,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1449,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1449,7,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
1449,8,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1449,9,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
1450,1,Genital infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1450,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1450,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
1450,4,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1450,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1450,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1450,7,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1450,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1450,9,Vulval abscess,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
1451,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1452,1,Adrenocortical carcinoma,Adrenal neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
1452,2,DNA mismatch repair protein gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
1452,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1453,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1453,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1454,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1454,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1455,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1456,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1457,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1458,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1459,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1460,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1461,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1462,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1463,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1464,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1464,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1464,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1465,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1465,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1465,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1466,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1467,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1468,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1469,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1469,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1469,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1470,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1470,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1470,3,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1470,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1471,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1472,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1472,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1472,3,Human herpesvirus 6 encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
1472,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1473,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1474,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1475,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1475,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1476,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1477,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1478,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1479,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1479,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1480,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1481,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1481,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1481,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1481,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1481,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1481,6,Pasteurella infection,Pasteurella infections,Bacterial infectious disorders,Infec,N
1481,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1482,1,Death neonatal,Death and sudden death,Fatal outcomes,Genrl,Y
1482,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1482,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1482,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1482,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1483,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1484,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1484,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1484,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1484,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1485,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1486,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1487,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1487,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1488,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1489,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1489,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
1490,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1490,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1491,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1492,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1493,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1494,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
1494,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1494,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1495,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
1495,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1495,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1496,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1497,1,Chronic myelomonocytic leukaemia,Myelodysplastic syndromes,Leukaemias,Neopl,N
1498,1,Adenoviral encephalitis,Adenoviral infections,Viral infectious disorders,Infec,N
1498,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1498,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1498,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1498,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1498,6,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1498,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1499,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1499,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1499,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1500,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1501,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1502,1,B-cell lymphoma recurrent,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1502,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1502,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1503,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1503,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1503,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1503,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1504,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1505,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1505,2,Anal inflammation,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
1505,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1505,4,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1505,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1505,6,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1505,7,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1505,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1505,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1505,10,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1505,11,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1505,12,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
1505,13,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1505,14,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1505,15,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1505,16,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1505,17,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
1505,18,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1505,19,SARS-CoV-2 test negative,Virus identification and serology,Microbiology and serology investigations,Inv,N
1505,20,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1506,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1507,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1508,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1509,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1509,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1510,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1510,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1511,1,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1511,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1511,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1511,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1512,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1512,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1513,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1513,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1513,3,Blastocystis infection,Blastocystis infections,Protozoal infectious disorders,Infec,N
1513,4,Differential white blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1513,5,Nail pigmentation,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1513,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1513,7,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1513,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1514,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1514,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1515,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1516,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1516,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1517,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1518,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1518,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1519,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1519,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1520,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1520,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1521,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1521,2,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1522,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1523,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1523,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1524,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1524,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1525,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1526,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1526,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1526,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1526,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1526,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1526,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1526,7,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1526,8,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1527,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1527,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1528,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1528,2,Encephalitis cytomegalovirus,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
1529,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1529,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1530,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1530,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1530,3,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
1530,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1530,5,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
1531,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1531,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1531,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1531,4,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1532,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1532,2,Mental fatigue,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
1533,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1533,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1533,3,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1533,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1534,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1534,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1534,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1535,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1535,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1535,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1535,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1535,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1535,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1535,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1535,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1535,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1536,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1536,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1537,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1537,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1537,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1538,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1538,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1539,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1539,2,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
1539,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1539,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1540,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1541,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1541,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1542,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1542,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1542,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1542,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1542,5,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1542,6,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1542,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1542,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1542,9,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1542,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1542,11,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1542,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1542,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1543,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1543,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1543,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1544,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1544,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1545,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1546,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1546,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1546,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1546,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1547,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1547,2,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1547,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1547,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1547,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1547,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1547,7,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1547,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1547,9,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1548,1,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1548,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1548,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1548,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1548,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1548,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
